SKI-1/S1P inhibition: a promising surrogate to statins to block hepatitis C virus replication. (Record no. 21808474)

MARC details
000 -LEADER
fixed length control field 01345 a2200349 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516093423.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201211s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1872-9096
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.antiviral.2012.05.006
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Blanchet, Matthieu
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20121107
245 00 - TITLE STATEMENT
Title SKI-1/S1P inhibition: a promising surrogate to statins to block hepatitis C virus replication.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Antiviral research
Date of publication, distribution, etc. Aug 2012
300 ## - PHYSICAL DESCRIPTION
Extent 159-66 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antiviral Agents
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Line
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Enzyme Inhibitors
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hepacivirus
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hepatocytes
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hydroxymethylglutaryl-CoA Reductase Inhibitors
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Proprotein Convertases
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrrolidines
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Serine Endopeptidases
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Virus Replication
General subdivision drug effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Seidah, Nabil G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Labonté, Patrick
773 0# - HOST ITEM ENTRY
Title Antiviral research
Related parts vol. 95
-- no. 2
-- p. 159-66
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.antiviral.2012.05.006">https://doi.org/10.1016/j.antiviral.2012.05.006</a>
Public note Available from publisher's website

No items available.